Table 2 Comedications among OST patients within the last 24 h before testing
Medications used within 24 hours of test | Methadone-treated patients (n = 16) | Â | Buprenorphine/Naloxone- treated patients (n = 17) | Â |
|---|---|---|---|---|
| Â | Proportion of patients | Dose, range | Proportion of patients | Dose, range |
Antidepressives (any) | 44 % | Â | 35'% | Â |
   Essitalopram | 6% | 5 mg |  |  |
   Citalopram | 6 % | 20 mg |  |  |
   Doxepine |  |  | 12% | 75 – 100 mg |
   Fluoxetine | 13% | 20 – 30 mg |  |  |
   Mirtazapine | 13% | 15 mg |  |  |
   Paroxetine |  |  | 6% | 50 mg |
   Sertraline | 6% | 50 mg | 12% | 50 mg |
   Venlaflaxine |  |  | 12% | 75 mg |
Anxiolytics, sedatives and hypnotics: | Â | Â | Â | Â |
Benzodiazepines (any) | 81 % | Â | 76% | Â |
   Diazepam | 38% | 5–20 mg | 29% | 15 -40 mg |
   Oxazepam | 44% | 45 – 120 mg | 47% | 30 – 90 mg |
   Nitratzepam* | 6% | 20 mg |  |  |
   Tematzepam * | 19% | 20 mg | 12% | 20 mg |
Non-benzodiazepine hypnotics (any) | 25% | Â | 35% | Â |
   Zolpidem * | 6% | 10 mg | 6% | 15 mg |
   Zopiclone * | 19% | 7.5 – 15 mg | 24% | 7.5 – 15 mg |
Neuroleptics †(any) | 25% |  | 18% |  |
   Chlorpromazine |  |  | 6% | 50 mg |
   Flupenthixole | 6% | 0.5 mg |  |  |
   Levomepromazine | 6% | 150 mg | 6% | 100 mg |
   Quetiapine | 13% | 50–100 mg | 6% | 300 mg |
Opioid withdrawal symptom or pain relievers (any) | 69 % | Â | 53% | Â |
   Hydroxyzine | 38% | 25–200 mg | 24% | 75 – 300 mg |
   Ibuprofeine | 13% | 600– 2400 mg | 6% | 400 mg |
   Lofexidine | 6% | 0.2mg | 18% | 0.2 – 0.6 mg |
   Metoclopramide | 6% | 10 mg |  |  |
   Naproxen | 6% | 500 mg | 6% | 500 mg |
   Propranol | 6% | 20 mg |  |  |
   Valproate | 13% | 500 – 1000 mg | 24% | 500 – 1000 mg |
None medication | 13% | Â | 12% | Â |